Variables | n | Mg intake (mg/kg) | P | Serum Mg (mmol/L) | P |
---|---|---|---|---|---|
Dietary intake | |||||
Energy intake (kcal/kg) | 0.000 | 0.636 | |||
< 25 | 109 | 2.8 ± 1.3 ab | 0.77 ± 0.10 | ||
25 to 30 | 47 | 4.0 ± 1.2 a | 0.79 ± 0.10 | ||
>30 | 54 | 4.6 ± 2.0 b | 0.79 ± 0.08 | ||
Protein intake (g/kg) | 0.000 | 0.172 | |||
< 0.8 | 115 | 2.9 ± 1.3 ab | 0.77 ± 0.10 | ||
0.8 to 1.0 | 48 | 3.7 ± 1.2 ac | 0.80 ± 0.09 | ||
>1.0 | 47 | 5.0 ± 2.0 bc | 0.79 ± 0.08 | ||
Physical activity level | 0.002 | 0.024 | |||
Low | 48 | 2.8 ± 1.4 a b | 0.79 ± 0.11 | ||
Moderate | 83 | 3.8 ± 1.7 a | 0.80 ± 0.09 c | ||
High | 79 | 3.8 ± 1.7 b | 0.76 ± 0.08 c | ||
Depression (DSM-IV) | 0.001 | 0.554 | |||
< 5 symptoms | 147 | 3.8 ± 1.7 | 0.78 ± 0.10 | ||
≧ 5 symptoms | 63 | 3.0 ± 1.4 | 0.78 ± 0.09 | ||
Metabolic parameters | |||||
HbA1c (%) | 0.709 | 0.558 | |||
< 7.0 | 103 | 3.6 ± 1.6 | 0.79 ± 0.08 | ||
≧ 7.0 | 107 | 3.5 ± 1.7 | 0.78 ± 0.11 | ||
HDL-cholesterol (mg/dL) | 0.051 | 0.659 | |||
≧ 40 for men or ≧ 50 for women | 114 | 3.8 ± 1.8 | 0.78 ± 0.09 | ||
< 40 for men or < 50 for women | 96 | 3.3 ± 1.5 | 0.78 ± 0.10 | ||
Triglycerides (mg/dL) | 0.452 | 0.456 | |||
< 150 | 172 | 3.6 ± 1.7 | 0.78 ± 0.10 | ||
≧ 150 | 38 | 3.4 ± 1.4 | 0.79 ± 0.08 | ||
Blood pressure (mmHg) | 0.344 | 0.669 | |||
Systolic BP < 130 / Diastolic BP < 80 | 64 | 3.7 ± 2.0 | 0.79 ± 0.09 | ||
Systolic BP ≧ 130 / Diastolic BP ≧ 80 | 146 | 3.5 ± 1.5 | 0.78 ± 0.10 | ||
Waist circumference (cm) | 0.000 | 0.687 | |||
< 80 for men or < 90 for women | 44 | 4.6 ± 2.2 | 0.78 ± 0.10 | ||
≧ 80 for men or ≧ 90 for women | 166 | 3.3 ± 1.4 | 0.78 ± 0.09 | ||
Metabolic syndrome | 0.013 | 0.234 | |||
< 3 components | 54 | 4.2 ± 2.3 | 0.80 ± 0.10 | ||
≧ 3 components | 156 | 3.3 ± 1.4 | 0.78 ± 0.09 | ||
Body Fat percentage (%) | 0.000 | 0.873 | |||
< 25 for men or < 30 for women | 101 | 4.0 ± 1.9 | 0.78 ± 0.09 | ||
≧ 25 for men or ≧ 30 for women (obese) | 109 | 3.1 ± 1.4 | 0.78 ± 0.10 | ||
Body mass index (kg/m2) | 0.000 | 0.803 | |||
< 27 | 151 | 3.9 ± 1.7 | 0.78 ± 0.10 | ||
≧ 27 (obese) | 59 | 2.8 ± 1.3 | 0.78 ± 0.09 | ||
High-sensitivity CRP (mg/L) | 0.246 | 0.186 | |||
< 1 Low risk | 57 | 3.9 ± 1.9 | 0.76 ± 0.10 | ||
1 to 3 Moderate risk | 105 | 3.5 ± 1.6 | 0.79 ± 0.10 | ||
> 3 High risk | 35 | 3.3 ± 1.5 | 0.80 ± 0.08 | ||
Estimated GFR(ml/min) | 0.067 | 0.363 | |||
≧ 90 CKD stage 1 | 30 | 4.0 ± 1.7 | 0.76 ± 0.10 | ||
60 - 89 CKD stage 2 | 121 | 3.6 ± 1.8 | 0.79 ± 0.09 | ||
30 - 59 CKD stage 3 | 59 | 3.1 ± 1.4 | 0.78 ± 0.11 |